The coagulation laboratory monitoring of Afstyla single-chain FVIII concentrate.

about

The coagulation laboratory monitoring of Afstyla single-chain FVIII concentrate.

Item

http://www.wikidata.org/entity/Q45869316

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The coagulation laboratory monitoring of Afstyla single-chain FVIII concentrate.

@en

The coagulation laboratory monitoring of Afstyla single-chain FVIII concentrate.

@nl

type

Item

label

The coagulation laboratory monitoring of Afstyla single-chain FVIII concentrate.

@en

The coagulation laboratory monitoring of Afstyla single-chain FVIII concentrate.

@nl

prefLabel

The coagulation laboratory monitoring of Afstyla single-chain FVIII concentrate.

@en

The coagulation laboratory monitoring of Afstyla single-chain FVIII concentrate.

@nl

P1476

The coagulation laboratory monitoring of Afstyla single-chain FVIII concentrate

@en

P2093

D Dalton

http://www.w3.org/2001/XMLSchema#string

N Key

http://www.w3.org/2001/XMLSchema#string

S Kitchen

http://www.w3.org/2001/XMLSchema#string

P2860

The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO.

A world-wide survey and field study in clinical haemostasis laboratories to evaluate FVIII:C activity assay variability of ADYNOVATE and OBIZUR in comparison with ADVATE.

Physicochemical characterisation of rVIII-SingleChain, a novel recombinant single-chain factor VIII.

Comparative field study evaluating the activity of recombinant factor VIII Fc fusion protein in plasma samples at clinical haemostasis laboratories.

Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94-9027) for haemophilia A.

Recombinant factor IX: discrepancies between one-stage clotting and chromogenic assays.

Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits: a two-center study.

P304

e469-e470

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HAE.13290

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Makris

A Bowyer

P577

2017-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28664616

http://www.w3.org/2001/XMLSchema#string